Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis | |
Feng, Fubin; Yin, Fang; Zhang, Tingting; Liu, Cun; Sun, Changgang | |
刊名 | EXPERT OPINION ON DRUG SAFETY
![]() |
2018 | |
卷号 | 17期号:12页码:1151-1152 |
DOI | 10.1080/17446651.2018.1545367 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4576928 |
专题 | 山东大学 |
作者单位 | 1.Weifang Tradit Chinese Hosp, Dept Oncol, 1055 Weizhou Rd, Weifang, Shandong, Peoples R China. 2.Weifang Peo |
推荐引用方式 GB/T 7714 | Feng, Fubin,Yin, Fang,Zhang, Tingting,et al. Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis[J]. EXPERT OPINION ON DRUG SAFETY,2018,17(12):1151-1152. |
APA | Feng, Fubin,Yin, Fang,Zhang, Tingting,Liu, Cun,&Sun, Changgang.(2018).Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis.EXPERT OPINION ON DRUG SAFETY,17(12),1151-1152. |
MLA | Feng, Fubin,et al."Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis".EXPERT OPINION ON DRUG SAFETY 17.12(2018):1151-1152. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论